Požymis
Weakness of one side of body
Klinikinis pavadinimas: Hemiparesis
Loss of strength in the arm, leg, and sometimes face on one side of the body. Hemiplegia refers to a complete loss of strength, whereas hemiparesis refers to an incomplete loss of strength.
Santrauka
- Kūno sistema
- Abnormality of the nervous system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Weakness of one side of body, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test118 genų susiję su Weakness of one side of body
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Weakness of one side of body. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| AMACRalpha-methylacyl-CoA racemase | Visada | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Visada | 2 ligose |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Visada | 1 ligoje |
| CNKSR2connector enhancer of kinase suppressor of Ras 2 | Visada | 1 ligoje |
| MAN2B2mannosidase alpha class 2B member 2 | Visada | 1 ligoje |
| MARK2microtubule affinity regulating kinase 2 | Visada | 1 ligoje |
| NIT1nitrilase 1 | Visada | 1 ligoje |
| NOS3nitric oxide synthase 3 | Visada | 1 ligoje |
| OAS22'-5'-oligoadenylate synthetase 2 | Visada | 1 ligoje |
| RFC4replication factor C subunit 4 | Visada | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Visada | 1 ligoje |
| TCP1t-complex 1 | Visada | 1 ligoje |
| UNC13Aunc-13 homolog A | Visada | 1 ligoje |
| GBE11,4-alpha-glucan branching enzyme 1 | Labai dažnai (80–99%) | 1 ligoje |
| ADA2adenosine deaminase 2 | Dažnai (30–79%) | 1 ligoje |
| ANGPTL6angiopoietin like 6 | Dažnai (30–79%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Dažnai (30–79%) | 2 ligose |
| CCR1C-C motif chemokine receptor 1 | Dažnai (30–79%) | 1 ligoje |
| COL3A1collagen type III alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| COL4A1collagen type IV alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| CYP26C1cytochrome P450 family 26 subfamily C member 1 | Dažnai (30–79%) | 1 ligoje |
| ENGendoglin | Dažnai (30–79%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Dažnai (30–79%) | 1 ligoje |
| FASFas cell surface death receptor | Dažnai (30–79%) | 1 ligoje |
| GUCY1A1guanylate cyclase 1 soluble subunit alpha 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Dažnai (30–79%) | 1 ligoje |
| IFNGR1interferon gamma receptor 1 | Dažnai (30–79%) | 1 ligoje |
| IL10interleukin 10 | Dažnai (30–79%) | 1 ligoje |
| IL12Ainterleukin 12A | Dažnai (30–79%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Dažnai (30–79%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Dažnai (30–79%) | 1 ligoje |
| KLRC4killer cell lectin like receptor C4 | Dažnai (30–79%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Dažnai (30–79%) | 1 ligoje |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Dažnai (30–79%) | 2 ligose |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Dažnai (30–79%) | 2 ligose |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Dažnai (30–79%) | 2 ligose |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Dažnai (30–79%) | 2 ligose |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Dažnai (30–79%) | 1 ligoje |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Dažnai (30–79%) | 2 ligose |
Rodyti dar 78 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Dažnai (30–79%) | 2 ligose |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Dažnai (30–79%) | 2 ligose |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Dažnai (30–79%) | 2 ligose |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Dažnai (30–79%) | 2 ligose |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Dažnai (30–79%) | 2 ligose |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Dažnai (30–79%) | 2 ligose |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Dažnai (30–79%) | 2 ligose |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Dažnai (30–79%) | 2 ligose |
| NOTCH3notch receptor 3 | Dažnai (30–79%) | 2 ligose |
| PLA2G6phospholipase A2 group VI | Dažnai (30–79%) | 1 ligoje |
| PRRT2proline rich transmembrane protein 2 | Dažnai (30–79%) | 1 ligoje |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Dažnai (30–79%) | 2 ligose |
| SLC2A1solute carrier family 2 member 1 | Dažnai (30–79%) | 2 ligose |
| STAT4signal transducer and activator of transcription 4 | Dažnai (30–79%) | 1 ligoje |
| TGFBR3transforming growth factor beta receptor 3 | Dažnai (30–79%) | 1 ligoje |
| THSD1thrombospondin type 1 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| TLR4toll like receptor 4 | Dažnai (30–79%) | 1 ligoje |
| TPP2tripeptidyl peptidase 2 | Dažnai (30–79%) | 1 ligoje |
| TUBB2Btubulin beta 2B class IIb | Dažnai (30–79%) | 2 ligose |
| UBAC2UBA domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| ABCD1ATP binding cassette subfamily D member 1 | Kartais (5–29%) | 1 ligoje |
| AGR2anterior gradient 2, protein disulphide isomerase family member | Kartais (5–29%) | 1 ligoje |
| AKT1AKT serine/threonine kinase 1 | Kartais (5–29%) | 1 ligoje |
| AKT3AKT serine/threonine kinase 3 | Kartais (5–29%) | 1 ligoje |
| ARHGAP31Rho GTPase activating protein 31 | Kartais (5–29%) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Kartais (5–29%) | 1 ligoje |
| CRELD1CRELD disulfide isomerase 1 | Kartais (5–29%) | 1 ligoje |
| DCCDCC netrin 1 receptor | Kartais (5–29%) | 1 ligoje |
| DLL4delta like canonical Notch ligand 4 | Kartais (5–29%) | 1 ligoje |
| DOCK6dedicator of cytokinesis 6 | Kartais (5–29%) | 1 ligoje |
| EOGTEGF domain specific O-linked N-acetylglucosamine transferase | Kartais (5–29%) | 1 ligoje |
| FGFR1fibroblast growth factor receptor 1 | Kartais (5–29%) | 1 ligoje |
| GNAQG protein subunit alpha q | Kartais (5–29%) | 1 ligoje |
| HIVEP2HIVEP zinc finger 2 | Kartais (5–29%) | 1 ligoje |
| HTRA1HtrA serine peptidase 1 | Kartais (5–29%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Kartais (5–29%) | 1 ligoje |
| MTHFRmethylenetetrahydrofolate reductase | Kartais (5–29%) | 1 ligoje |
| MTORmechanistic target of rapamycin kinase | Kartais (5–29%) | 2 ligose |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Kartais (5–29%) | 2 ligose |
| NOTCH1notch receptor 1 | Kartais (5–29%) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Kartais (5–29%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Kartais (5–29%) | 2 ligose |
| PRORPprotein only RNase P catalytic subunit | Kartais (5–29%) | 1 ligoje |
| RBPJrecombination signal binding protein for immunoglobulin kappa J region | Kartais (5–29%) | 1 ligoje |
| RHOBTB2Rho related BTB domain containing 2 | Kartais (5–29%) | 1 ligoje |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Kartais (5–29%) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Kartais (5–29%) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Kartais (5–29%) | 1 ligoje |
| SMOsmoothened, frizzled class receptor | Kartais (5–29%) | 1 ligoje |
| SP110SP110 nuclear body protein | Kartais (5–29%) | 1 ligoje |
| SPOPspeckle type BTB/POZ protein | Kartais (5–29%) | 1 ligoje |
| SUFUSUFU negative regulator of hedgehog signaling | Kartais (5–29%) | 1 ligoje |
| TBC1D24TBC1 domain family member 24 | Kartais (5–29%) | 2 ligose |
| TBX1T-box transcription factor 1 | Kartais (5–29%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Kartais (5–29%) | 1 ligoje |
| TRAF7TNF receptor associated factor 7 | Kartais (5–29%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Kartais (5–29%) | 2 ligose |
| DNM1Ldynamin 1L | Retai (1–4 %) | 1 ligoje |
| HRASHRas proto-oncogene, GTPase | Retai (1–4 %) | 1 ligoje |
| OPA1OPA1 mitochondrial dynamin like GTPase | Retai (1–4 %) | 1 ligoje |
| PPIBpeptidylprolyl isomerase B | Retai (1–4 %) | 1 ligoje |
| TLR3toll like receptor 3 | Retai (1–4 %) | 1 ligoje |
| ANO1anoctamin 1 | Neužfiksuota | 1 ligoje |
| CFHcomplement factor H | Neužfiksuota | 1 ligoje |
| CFHR1complement factor H related 1 | Neužfiksuota | 1 ligoje |
| CFHR3complement factor H related 3 | Neužfiksuota | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Neužfiksuota | 1 ligoje |
| MT-CYBmitochondrially encoded cytochrome b | Neužfiksuota | 1 ligoje |
| MT-TCmitochondrially encoded tRNA-Cys (UGU/C) | Neužfiksuota | 1 ligoje |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Neužfiksuota | 1 ligoje |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Neužfiksuota | 1 ligoje |
| MT-TVmitochondrially encoded tRNA-Val (GUN) | Neužfiksuota | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Neužfiksuota | 1 ligoje |
| TBK1TANK binding kinase 1 | Neužfiksuota | 1 ligoje |
| TSC1TSC complex subunit 1 | Neužfiksuota | 1 ligoje |
| TSC2TSC complex subunit 2 | Neužfiksuota | 1 ligoje |
| TTRtransthyretin | Neužfiksuota | 1 ligoje |
| WDR62WD repeat domain 62 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites